Related references
Note: Only part of the references are listed.NRAS Mutation Is the Sole Recurrent Somatic Mutation in Large Congenital Melanocytic Nevi
Christelle Charbel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor
Heidi V. N. Kusters-Vandevelde et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Multiple Congenital Melanocytic Nevi and Neurocutaneous Melanosis Are Caused by Postzygotic Mutations in Codon 61 of NRAS
Veronica A. Kinsler et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR-ErbB2 signaling with lapatinib
Anjali Singh et al.
MOLECULAR ONCOLOGY (2013)
Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis
Daniel J. Lindner et al.
MATRIX BIOLOGY (2013)
Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma
Xinqi Wu et al.
PLOS ONE (2013)
Primary Melanoma of the CNS in Children Is Driven by Congenital Expression of Oncogenic NRAS in Melanocytes
Malin Pedersen et al.
CANCER DISCOVERY (2013)
Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells
Arun Satelli et al.
CANCER LETTERS (2011)
Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R
Kerrington R. Molhoek et al.
MELANOMA RESEARCH (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Heat shock proteins as targets in oncology
Alejandra Gimenez Ortiz et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
The Risk of Melanoma and Neurocutaneous Melanosis Associated with Congenital Melanocytic Nevi
Kara N. Shah
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2010)
Giant Congenital Melanocytic Nevi
Jugpal S. Arneja et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2009)
Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines
A. Sorolla et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Thrombospondins in cancer
S. Kazerounian et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin
Caroline Hilmi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency
Anna Polesskaya et al.
GENES & DEVELOPMENT (2007)
Asymptomatic neurocutaneous melanocytosis in patients with large congenital melanocytic nevi: A study of cases from an Internet-based registry
ALC Agero et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Insulin-like growth factor I-stimulated melanoma cell migration requires phosphoinositide 3-kinase but not extracellular-regulated kinase activation
CL Neudauer et al.
EXPERIMENTAL CELL RESEARCH (2003)
Share Paper
